Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced it has received clinical laboratory accreditation from the New York State Department of ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results